141 related articles for article (PubMed ID: 8718759)
1. Innovations in aneurysmal subarachnoid hemorrhage: intracisternal t-PA for the prevention of vasospasm.
Bell TE; Kongable GL
J Neurosci Nurs; 1996 Apr; 28(2):107-13. PubMed ID: 8718759
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
Zabramski JM; Spetzler RF; Lee KS; Papadopoulos SM; Bovill E; Zimmerman RS; Bederson JB
J Neurosurg; 1991 Aug; 75(2):189-96. PubMed ID: 1906534
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
[TBL] [Abstract][Full Text] [Related]
4. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage.
Findlay JM; Weir BK; Kassell NF; Disney LB; Grace MG
J Neurosurg; 1991 Aug; 75(2):181-8. PubMed ID: 1906533
[TBL] [Abstract][Full Text] [Related]
5. Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage.
Steinberg GK; Vanefsky MA; Marks MP; Adler JR; Koenig GH
Neurosurgery; 1994 May; 34(5):809-13; discussion 813-4. PubMed ID: 8052377
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary clinical trial of intrathecal rt-PA (TD-2061) for the prevention of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage].
Sasaki T; Ohta T; Kikuch H; Takakura K; Usui M; Kondoh A; Tanabe H; Nakamura J; Yamada K
No To Shinkei; 1992 Nov; 44(11):1001-8. PubMed ID: 1296711
[TBL] [Abstract][Full Text] [Related]
7. Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients.
Kodama N; Sasaki T; Kawakami M; Sato M; Asari J
Surg Neurol; 2000 Feb; 53(2):110-7; discussion 117-8. PubMed ID: 10713187
[TBL] [Abstract][Full Text] [Related]
8. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage.
Ohman J; Servo A; Heiskanen O
J Neurosurg; 1991 Aug; 75(2):197-201. PubMed ID: 1906535
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal fibrinolysis using recombinant tissue plasminogen activator (rTPA) for prevention of cerebral vasospasm and delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage. Experimental and clinical data.
Seifert V
Neurol Res; 1994 Feb; 16(1):54-8. PubMed ID: 7913533
[TBL] [Abstract][Full Text] [Related]
10. Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna: a prospective randomized study.
Hamada J; Kai Y; Morioka M; Yano S; Mizuno T; Hirano T; Kazekawa K; Ushio Y
Stroke; 2003 Nov; 34(11):2549-54. PubMed ID: 14563967
[TBL] [Abstract][Full Text] [Related]
11. Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage.
Kinouchi H; Ogasawara K; Shimizu H; Mizoi K; Yoshimoto T
Neurol Med Chir (Tokyo); 2004 Nov; 44(11):569-75; discussion 576-7. PubMed ID: 15686175
[TBL] [Abstract][Full Text] [Related]
12. Thrombolytic therapy with tissue plasminogen activator for prevention of vasospasm in experimental subarachnoid hemorrhage: its efficacy and problems.
Asada M; Kong J; Nakamura M; Tamaki N
Neurol Res; 1996 Aug; 18(4):342-4. PubMed ID: 8875453
[TBL] [Abstract][Full Text] [Related]
13. Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Mori K; Arai H; Nakajima K; Tajima A; Maeda M
Stroke; 1995 Sep; 26(9):1620-6. PubMed ID: 7660409
[TBL] [Abstract][Full Text] [Related]
14. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Findlay JM; Macdonald RL; Weir BK
Cerebrovasc Brain Metab Rev; 1991; 3(4):336-61. PubMed ID: 1772740
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage.
Seifert V; Eisert WG; Stolke D; Goetz C
Neurosurgery; 1989 Oct; 25(4):590-8. PubMed ID: 2507953
[TBL] [Abstract][Full Text] [Related]
16. Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms: report on 69 cases.
Murayama Y; Malisch T; Guglielmi G; Mawad ME; Viñuela F; Duckwiler GR; Gobin YP; Klucznick RP; Martin NA; Frazee J
J Neurosurg; 1997 Dec; 87(6):830-5. PubMed ID: 9384391
[TBL] [Abstract][Full Text] [Related]
17. Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage.
Lasner TM; Weil RJ; Riina HA; King JT; Zager EL; Raps EC; Flamm ES
J Neurosurg; 1997 Sep; 87(3):381-4. PubMed ID: 9285602
[TBL] [Abstract][Full Text] [Related]
18. Cerebral vasospasm and calcium channel blockade. Nimodipine treatment in patients with aneurysmal subarachnoid hemorrhage.
Brandt L; Ljunggren B; Säveland H; Andersson KE; Vinge E
Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():151-5. PubMed ID: 3521193
[TBL] [Abstract][Full Text] [Related]
19. Effect of BQ-123 and tissue plasminogen activator on vasospasm after subarachnoid hemorrhage in monkeys.
Kim CJ; Bassiouny M; Macdonald RL; Weir B; Johns LM
Stroke; 1996 Sep; 27(9):1629-33. PubMed ID: 8784140
[TBL] [Abstract][Full Text] [Related]
20. Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator: preliminary report.
Mizoi K; Yoshimoto T; Fujiwara S; Sugawara T; Takahashi A; Koshu K
Neurosurgery; 1991 Jun; 28(6):807-12; discussion 812-3. PubMed ID: 1906142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
